Journal
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Volume 22, Issue 7, Pages 739-748Publisher
SPRINGER
DOI: 10.1007/s00384-006-0228-0
Keywords
colorectal cancer; microsatellite instability (MSI-H); chemotherapy; 5 fluorouracil (5FU); cyclo-oxygenase 2 (COX-2); irinotecan
Categories
Ask authors/readers for more resources
Introduction High-frequency microsatellite instability (MSI-H) is an alternate pathway of colorectal carcinogenesis, which accounts for 15% of all sporadic colorectal cancers. These tumours arise from mutations in the DNA mismatch repair system and thus have different responses to chemotherapeutic agents compared to inicrosatellite stable (MSS) cancers. Objective This review aims to summarise the available literature on the responses to chemotherapy in MSI-H colorectal cancer (CRC). Results and discussion 5 Fluorouracil (5FU) is commonly used as a chemotherapeutic agent in colon cancer and in vitro evidence shows reduced response to 5FU in MSI-H CRC. The clinical evidence is conflicting but favours a reduced response to 5FU in MSI-H CRC. Several newer agents such as COX-2 inhibitors and irinotecan are also reviewed. Conclusion Available evidence suggests that MSI-H CRC have different behaviour pattems and response to chemotherapy compared with MSS CRC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available